LTT Bio-Pharma Co., Ltd. - Product Pipeline Review - 2014

Date: July 22, 2014
Pages: 27
Price:
US$ 1,500.00 US$ 1,125.00
Offer valid until December 31, 2016!
License [?]:
Publisher: Global Markets Direct
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: LB952593F99EN
Leaflet:

Download PDF Leaflet

Summary

Global Markets Direct’s, ‘LTT Bio-Pharma Co., Ltd. - Product Pipeline Review - 2014’, provides an overview of the LTT Bio-Pharma Co., Ltd.’s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of LTT Bio-Pharma Co., Ltd.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope
  • The report provides brief overview of LTT Bio-Pharma Co., Ltd. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of LTT Bio-Pharma Co., Ltd.’s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the LTT Bio-Pharma Co., Ltd.’s pipeline products
Reasons to buy
  • Evaluate LTT Bio-Pharma Co., Ltd.’s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of LTT Bio-Pharma Co., Ltd. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the LTT Bio-Pharma Co., Ltd.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of LTT Bio-Pharma Co., Ltd. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of LTT Bio-Pharma Co., Ltd.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope
  • Explore the dormant and discontinued projects of LTT Bio-Pharma Co., Ltd. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues
LTT Bio-Pharma Co., Ltd. Snapshot
LTT Bio-Pharma Co., Ltd. Overview
Key Information
Key Facts
LTT Bio-Pharma Co., Ltd. - Research and Development Overview
Key Therapeutic Areas
LTT Bio-Pharma Co., Ltd. - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
LTT Bio-Pharma Co., Ltd. - Pipeline Products Glance
LTT Bio-Pharma Co., Ltd. - Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
LTT Bio-Pharma Co., Ltd. - Early Stage Pipeline Products
Discovery Products/Combination Treatment Modalities
LTT Bio-Pharma Co., Ltd. - Drug Profiles
ecraprost
Product Description
Mechanism of Action
R&D Progress
PC-SOD
Product Description
Mechanism of Action
R&D Progress
G-CSF SR
Product Description
Mechanism of Action
R&D Progress
LT-0101
Product Description
Mechanism of Action
R&D Progress
LT-0201
Product Description
Mechanism of Action
R&D Progress
LT-0301
Product Description
Mechanism of Action
R&D Progress
LTT Bio-Pharma Co., Ltd. - Pipeline Analysis
LTT Bio-Pharma Co., Ltd. - Pipeline Products by Target
LTT Bio-Pharma Co., Ltd. - Pipeline Products by Route of Administration
LTT Bio-Pharma Co., Ltd. - Pipeline Products by Molecule Type
LTT Bio-Pharma Co., Ltd. - Pipeline Products by Mechanism of Action
LTT Bio-Pharma Co., Ltd. - Dormant Projects
LTT Bio-Pharma Co., Ltd. - Locations And Subsidiaries
Head Office
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

LIST OF TABLES

LTT Bio-Pharma Co., Ltd., Key Information
LTT Bio-Pharma Co., Ltd., Key Facts
LTT Bio-Pharma Co., Ltd. - Pipeline by Indication, 2014
LTT Bio-Pharma Co., Ltd. - Pipeline by Stage of Development, 2014
LTT Bio-Pharma Co., Ltd. - Monotherapy Products in Pipeline, 2014
LTT Bio-Pharma Co., Ltd. - Phase II, 2014
LTT Bio-Pharma Co., Ltd. - Discovery, 2014
LTT Bio-Pharma Co., Ltd. - Pipeline by Target, 2014
LTT Bio-Pharma Co., Ltd. - Pipeline by Route of Administration, 2014
LTT Bio-Pharma Co., Ltd. - Pipeline by Molecule Type, 2014
LTT Bio-Pharma Co., Ltd. - Pipeline Products by Mechanism of Action, 2014
LTT Bio-Pharma Co., Ltd. - Dormant Developmental Projects,2014

LIST OF FIGURES

LTT Bio-Pharma Co., Ltd. - Pipeline by Top 10 Indication, 2014
LTT Bio-Pharma Co., Ltd. - Pipeline by Stage of Development, 2014
LTT Bio-Pharma Co., Ltd. - Monotherapy Products in Pipeline, 2014
LTT Bio-Pharma Co., Ltd. - Pipeline by Top 10 Target, 2014
LTT Bio-Pharma Co., Ltd. - Pipeline by Top 10 Route of Administration, 2014
LTT Bio-Pharma Co., Ltd. - Pipeline by Top 10 Molecule Type, 2014
LTT Bio-Pharma Co., Ltd. - Pipeline Products by Top 10 Mechanism of Action, 2014
Skip to top


Noxxon Pharma AG - Product Pipeline Review - 2016 US$ 1,500.00 Sep, 2016 · 36 pages
Neurotec Pharma SL - Product Pipeline Review - 2015 US$ 1,275.00 Nov, 2015 · 24 pages
Sigmoid Pharma Limited - Product Pipeline Review - 2016 US$ 1,275.00 Mar, 2016 · 33 pages
Ziarco Pharma Ltd - Product Pipeline Review - 2015 US$ 1,275.00 Dec, 2015 · 27 pages

Ask Your Question

LTT Bio-Pharma Co., Ltd. - Product Pipeline Review - 2014
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: